Dr. Reema Bhatt, M.D.
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 129
Licensed in Illinois since 2015, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
NY license 293577 -
Cardiovascular Disease Physician
IL license 036138075 (first issued 2015; not renewed) -
Internal Medicine Physician
PA license MT202610
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- New York-Presbyterian Hospital New York, NY
- New York-Presbyterian/queens Flushing, NY
Medical groups
- Weill Medical College of Cornell (2,051 clinicians)
- New York Queens Medicine and Surgery, P.c. (401 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 129
- Services billed
- 333
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 112 | 52 |
| Established patient office or other outpatient visit, 40-54 minutes | 81 | 47 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 63 | 58 |
| Insertion of needle into vein for collection of blood sample | 40 | 24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | 20 |
| Critical care, first 30-74 minutes | 19 | 11 |
| New patient office or other outpatient visit, 60-74 minutes | 13 | 13 |
| Established patient office or other outpatient visit, 30-39 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Flushing, NY | 30 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Flushing, NY | 24 |
| Vyndamax (tafamidis) | 21 |
| Eliquis (apixaban) Other prescribers in Flushing, NY | 14 |
| Carvedilol Other prescribers in Flushing, NY | 12 |
| Furosemide Other prescribers in Flushing, NY | 12 |
| Entresto (sacubitril/valsartan) Other prescribers in Flushing, NY | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 32 payments worth $1,453 in total to this clinician.
| Abbott Laboratories | $680 |
|---|---|
| Ebr Systems, Inc. | $449 |
| Cvrx, Inc. | $192 |
| E.r. Squibb & Sons, L.l.c. | $82.32 |
| Alnylam Pharmaceuticals Inc. | $50.50 |
| Food and Beverage | $1,453 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $31,906 in research payments for these studies, mostly to the institutions running them.
- PROACTIVE-HF
Endotronix, Inc. - LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
Boston Scientific Corporation · Completed · NCT04790344
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.